Avastin Approved as Second-Line Treatment
for Colon Cancer
In 2004, the U.S. Food and Drug Administration (FDA) approved
Avastin as a treatment for colon or rectal cancer that had spread
to other parts of the body. Avastin was the first drug ever
to be approved that works by choking off a tumor's blood supply.
Now, the U.S. Food and Drug Administration has approved it for
use as a second-line treatment as well.Study Assesses Link Between
Asbestos and Colorectal Cancer
While some studies have established a clear link between asbestos
exposure and colorectal cancer, others have found no relationship
between the two whatsoever. To address this issue, the Institute
of Medicine of the National Academies assessed more than 120
studies in an effort to determine once and for all, if asbestos
causes cancer of the throat and digestive system.
Study Explains Why Exercising Aids
in Colon Cancer Survival
A recent study published in the journal Gut explains why exercising
can increase a person's chances of surviving colon cancer. The
gist is that physical activity decreases insulin-like growth
factor 1 (IGF-1) and increases insulin-like growth factor binding
protein (IGFBP-3).
Birth Size and Colorectal Cancer Risk
Do you remember what your birth length was? Me neither. Never
really had a reason to. But a new study has made those seemingly-useless
baby stats relevant to our adult lives.
Chemoradiation Before Surgery Helps
Prevent Rectal Cancer Recurrence
A study found that patients with stage II or III rectal cancer
who received chemotherapy and radiation before rectal cancer
surgery were less likely to have a recurrence than patients
who received chemo and radiation after surgery.
